Brought to you by 
MorphoSys, Roche develop Alzheimer's therapeutics
07 Mar 2017
Executive Summary
MorphoSys (technologies to produce antibodies) will collaborate with Roche on the development of human antibodies to treat Alzheimer's disease.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Molecular Diversity
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com